CCL2 and Abdominal obesity: Moreover, after the intervention, subjects in the marine omega-3 group had a higher reduction in the prevalence of abdominal obesity compared to the active placebo group, and better differences between IL-6, IL-10, MCP-1, and RvD1 changes at the end of the study.